HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mumps in Poland in 2005].

Abstract
In 2005, 71,945 cases of mumps were reported in Poland. The incidence (188.5 per 100,000) was lower compared to 2004 (354.1), when the highest mumps incidence was recorded since 1999. The recently observed improvement in the epidemiological situation of mumps (trend towards lower and less frequent epidemic peaks) reflect the use of measles-mumps-rubella vaccine which was increasingly acquired by parents at their own expense during the last decade. Mandatory, free of charge, vaccination of children aged 13-14 months with trivalent measles-mumps-rubella vaccine was implemented at the end of 2003. The vaccination coverage among 3-year olds in 2005 reached 90.5%. Approximately 4.3% of cases were hospitalized (3105) and no deaths attributed to mumps were reported. Children 5-9 year old were the most affected age group (incidence 1569.7 per 100,000).
AuthorsPaweł Stefanoff
JournalPrzeglad epidemiologiczny (Przegl Epidemiol) Vol. 61 Issue 2 Pg. 195-8 ( 2007) ISSN: 0033-2100 [Print] Poland
Vernacular TitleSwinka w 2005 roku.
PMID17956031 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Measles-Mumps-Rubella Vaccine
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Incidence
  • Infant
  • Male
  • Mass Vaccination (statistics & numerical data)
  • Measles-Mumps-Rubella Vaccine (administration & dosage)
  • Mumps (epidemiology, prevention & control)
  • Poland (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: